Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Protagonist Therapeutics, Inc (PTGX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 8-K Quarterly results
Docs: "Protagonist Reports Second Quarter 2023 Financial Results and Provides Corporate Update"
05/04/2023 8-K Quarterly results
Docs: "Protagonist Reports First Quarter 2023 Financial Results and Provides Corporate Update"
03/15/2023 8-K Quarterly results
Docs: "Protagonist Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update"
11/08/2022 8-K Quarterly results
05/04/2022 8-K Quarterly results
02/28/2022 8-K Quarterly results
Docs: "Protagonist Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update"
11/03/2021 8-K Quarterly results
Docs: "Protagonist Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update"
08/04/2021 8-K Quarterly results
05/04/2021 8-K Quarterly results
11/04/2020 8-K Quarterly results
Docs: "Protagonist Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update",
"Protagonist Therapeutics to Present Updated Clinical Data for Hepcidin Mimetic PTG-300 in Polycythemia Vera at the American Society for Hematology 2020 Annual Meeting"
08/06/2020 8-K Quarterly results
05/07/2020 8-K Quarterly results
03/10/2020 8-K Quarterly results
11/06/2019 8-K Quarterly results
Docs: "Protagonist Therapeutics Reports Third Quarter 2019 Financial Results"
08/07/2019 8-K Quarterly results
Docs: "Protagonist Therapeutics Reports Second Quarter 2019 Financial Results"
05/08/2019 8-K Quarterly results
Docs: "Protagonist Therapeutics Reports First Quarter 2019 Financial Results"
03/12/2019 8-K Quarterly results
Docs: "Protagonist Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results"
11/06/2018 8-K Quarterly results
Docs: "Protagonist Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update"
05/09/2018 8-K Quarterly results
Docs: "Protagonist Therapeutics Reports First Quarter 2018 Financial Results"
03/07/2018 8-K Quarterly results
Docs: "Protagonist Therapeutics Reports Fourth Quarter and Year-End 2017 Financial Results Protagonist to host conference call today at 1:30 pm PT/4:30 pm ET"
11/06/2017 8-K Quarterly results
Docs: "Protagonist Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update"
08/08/2017 8-K Quarterly results
Docs: "Protagonist Therapeutics Reports Second Quarter 2017 Financial Results and Business Highlights Worldwide co-development agreement with Janssen for PTG-200 brings $50M upfront and potentially up to $940M in milestones Q2 cash balance of $64.5M - Cash to middle of 2019"
05/10/2017 8-K Form 8-K - Current report
03/07/2017 8-K Form 8-K - Current report
11/14/2016 8-K Quarterly results
Docs: "Protagonist Therapeutics Reports Third Quarter 2016 Financial Results and Provides Corporate Update"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy